Stay updated on Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Locations section adds numerous new sites across the US, Canada, Europe, Australia, and other regions, and removes many previously listed sites. This expands and reduces where participants can enroll in the study.SummaryDifference3%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedRevision: v3.3.2 was added and Revision: v3.2.0 was removed from the page.SummaryDifference0.3%

- Check49 days agoChange DetectedNotice about government funding and operating status has been removed. The removal does not affect the study details, eligibility criteria, or results.SummaryDifference0.2%

- Check64 days agoChange DetectedNo significant additions or deletions to core content were observed on the Study Details page; the main sections (Overview, Eligibility, Plan, Locations) remain as before.SummaryDifference0.2%

- Check93 days agoChange DetectedAdded a prominent operating-status notice and a new software version (v3.2.0), replacing the old version tag v3.1.0. This signals potential delays in data processing and updated status information.SummaryDifference2%

- Check100 days agoChange DetectedUpdate location name from Blankenfelde to Blankenfelde-Mahlow and bump revision from v3.0.2 to v3.1.0.SummaryDifference0.3%

Stay in the know with updates to Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Extension Study of Upadacitinib in Atopic Dermatitis Clinical Trial page.